:CHNG has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
:CHNG has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
As of today (2024-06-19), Change Healthcare's Intrinsic Value: Projected FCF is $0.00. The stock price of Change Healthcare is $27.49. Therefore, Change Healthcare's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.
The historical rank and industry rank for Change Healthcare's Intrinsic Value: Projected FCF or its related term are showing as below:
The historical data trend for Change Healthcare's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change Healthcare Annual Data | |||||||||||||||
Trend | Mar17 | Mar18 | Mar19 | Mar20 | Mar21 | Mar22 | |||||||||
Intrinsic Value: Projected FCF | Get a 7-Day Free Trial | - | - | - | - | - |
Change Healthcare Quarterly Data | |||||||||||||||||||
Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | |
Intrinsic Value: Projected FCF | Get a 7-Day Free Trial | - | - | - | - | - |
For the Health Information Services subindustry, Change Healthcare's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Change Healthcare's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Change Healthcare's Price-to-Projected-FCF falls into.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)
In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):
Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)
Change Healthcare (NAS:CHNG) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Change Healthcare's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF | = | Share Price | / | Intrinsic Value: Projected FCF |
= | 27.49 | / | ||
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Change Healthcare's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Tracy Byers | officer: SVP and GM, Enterprise Imaging | C/O CHANGE HEALTHCARE INC. 424 CHURCH STREET, SUITE 1400 NASHVILLE TN 37219 |
Steven B. Martin | officer: EVP, Enterprise Technology | 3055 LEBANON PIKE SUITE 1000 NASHVILLE TN 37214 |
Nella Domenici | director | C/O ALLIANCEBERNSTEIN, 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105 |
Paul Rareshide | officer: SVP, Corporate Controller | C/O CHANGE HEALTHCARE INC. 3055 LEBANON PIKE, SUITE 1000 NASHVILLE TN 37214 |
Fredrik J Eliasson | officer: EVP & CFO | 500 WATER STREET, JACKSONVILLE FL 32202 |
De Crescenzo Neil E. | director, officer: President & CEO | C/O CHANGE HEALTHCARE INC. 3055 LEBANON PIKE, SUITE 1000 NASHVILLE TN 37214 |
Diana Mckenzie | director | METLIFE, 200 PARK AVENUE, NEW YORK NY 10166 |
Roderick H. O'reilly | officer: See Remarks | C/O CHANGE HEALTHCARE INC., 3055 LEBANON PIKE, SUITE 1000, NASHVILLE TN 37214 |
August Calhoun | officer: See Remarks | C/O CHANGE HEALTHCARE INC. 3055 LEBANON PIKE, SUITE 1000 NASHVILLE TN 37214 |
Thomas Mcenery | officer: EVP & Chief Marketing Officer | |
Bansi Nagji | director | MCKESSON CORPORATION, 6555 STATE HIGHWAY 161, IRVING TX 75039 |
Alex P. Choy | officer: See Remarks | C/O CHANGE HEALTHCARE INC. 3055 LEBANON PIKE, SUITE 1000 NASHVILLE TN 37214 |
Linda Whitley-taylor | officer: EVP & Chief People Officer | C/O BENSON HILL, INC., 1001 NORTH WARSON ROAD, SAINT LOUIS MO 63132 |
Phillip W. Roe | director | 20 BURTON HILLS BOULEVARD SUITE 100 NASHVILLE TN 37215 |
Kriten Joshi | officer: See Remarks | C/O CHANGE HEALTHCARE INC. 3055 LEBANON PIKE, SUITE 1000 NASHVILLE TN 37214 |
From GuruFocus
By GuruFocus Research GuruFocus Editor • 02-11-2023
By Business Wire Business Wire • 04-05-2022
By Business Wire Business Wire • 05-12-2022
By GuruFocus Research GuruFocus Editor • 02-18-2023
By Business Wire Business Wire • 01-20-2022
By Business Wire Business Wire • 10-21-2021
By GuruFocus Research GuruFocus Editor • 11-15-2022
By GuruFocus Research GuruFocus Editor • 10-20-2022
By GuruFocus Research GuruFocus Editor • 02-18-2023
By Business Wire Business Wire • 06-22-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.